Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases

M Herre, J Cedervall, N Mackman… - Physiological …, 2023 - journals.physiology.org
Neutrophil extracellular trap (NET) formation, first described in 2004 as a previously
unknown strategy of neutrophils to fight microbes, has attracted an increasing interest in the …

Diabetic complications and prospective immunotherapy

L Reynolds, Z Luo, K Singh - Frontiers in Immunology, 2023 - frontiersin.org
The incidence of Diabetes Mellitus is increasing globally. Individuals who have been
burdened with diabetes for many years often develop complications as a result of …

Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer

T Guan, Y Jiang, Z Luo, Y Liang, M Feng, Z Lu… - Age and …, 2023 - academic.oup.com
Background previous studies have focused on the risk of cardiovascular disease (CVD)-
related death in individual cancers, adolescents or all cancers. Objective to evaluate the risk …

[HTML][HTML] Mechanisms of cancer-associated thrombosis

Y Hisada, N Mackman - Research and practice in thrombosis and …, 2023 - Elsevier
A State-of-the-Art lecture titled “Mechanisms of cancer-associated thrombosis” was
presented at the ISTH Congress in 2022. Patients with cancer have a 4-fold to 9-fold …

The emerging role of neutrophil extracellular traps in cancer: from lab to ward

W Zhong, Q Wang, X Shen, J Du - Frontiers in Oncology, 2023 - frontiersin.org
Neutrophil extracellular traps (NETs) are web-like structures derived from neutrophils, which
typically consist of DNA, released from the nucleus or mitochondria, and decorated with …

Trial watch: dexmedetomidine in cancer therapy

K Carnet Le Provost, O Kepp, G Kroemer… - …, 2024 - Taylor & Francis
Dexmedetomidine (DEX) is a highly selective α2-adrenoceptor agonist that is widely used in
intensive and anesthetic care for its sedative and anxiolytic properties. DEX has the capacity …

Liraglutide enhances the effect of checkpoint blockade in lung and liver cancers through the inhibition of neutrophil extracellular traps

D Chen, H Liang, L Huang, H Zhou, Z Wang - FEBS Open Bio, 2024 - Wiley Online Library
Glucagon‐like peptide‐1 (GLP‐1) regulates glycemic excursions by augmenting insulin
production and inhibiting glucagon secretion. Liraglutide, a long‐acting GLP‐1 analog, can …

Cancer-associated thrombosis: Epidemiology, pathophysiological mechanisms, treatment, and risk assessment

D Pavlovic, D Niciforovic… - Clinical Medicine …, 2023 - journals.sagepub.com
Cancer patients represent a growing population with drastically difficult care and a lowered
quality of life, especially due to the heightened risk of vast complications. Thus, it is well …

Plasma H3Cit-DNA discriminates between cancer and inflammation in a cohort of patients with unspecific cancer symptoms

F Wannberg, V Hjalmar, H Ng, C Johansson, F Probert… - Inflammation, 2024 - Springer
Cancer detection is challenging, especially in patients with unspecific cancer symptoms.
Biomarkers could identify patients at high risk of cancer. Prior studies indicate that neutrophil …

Long-term cardiovascular mortality among 80,042 older patients with bladder cancer

T Guan, M Su, Z Luo, W Peng, R Zhou, Z Lu, M Feng… - Cancers, 2022 - mdpi.com
Simple Summary We conducted a large-scale population-based study with long-term follow-
up to obtain a comprehensive assessment of death causes, especially cardiovascular …